Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy
机构:[1]Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital, Jinan, China,[2]Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院
Purpose: The purpose of the research was to assess the prognostic value of three-dimensional (3D) texture features based on diffusion-weighted magnetic resonance imaging (DWI) for esophageal squamous cell carcinoma (ESCC) patients undergoing concurrent chemo-radiotherapy (CRT). Methods: We prospectively enrolled 82 patients with ESCC into a cohort study. Two DWI sequences (b = 0 and b = 600 s/mm(2)) were acquired along with axial T2WI and T1WI before CRT. Two groups of features were examined: (1) clinical and demographic features (e.g., TNM stage, age and sex) and (2) changes in spatial texture characteristics of the apparent diffusion coefficient (ADC), which characterizes gray intensity changes in tumor areas, spatial pattern and distribution, and related changes caused by CRT. Reproducible feature sets without redundancy were statistically filtered and validated. The prognostic values associated with overall survival (OS) for each parameter were studied using Kaplan-Meier and Cox regression models for univariate and multivariate analyses, respectively. Results: Both univariate and multivariate Cox model analyses showed that the energy of intensity histogram texture (IHIST_energy), radiation dose, mean of the contrast in distance 1 of 26 directions (m_contrast_1), extreme difference of the homogeneity in distance 2 of 26 directions (Diff_homogeneity_2), mean of the inverse variance in distance 2 of 26 directions (m_lnversevariance_2), high-intensity small zone emphasis (HISE), and low-intensity large zone emphasis (LILE) were significantly associated with survival. The results showed that 6 texture parameters extracted from the ADC images before treatment could distinguish among high-, medium-, and low-risk groups (log-rank chi(2) = 9.7; P = 0.00773). The biased C-index value was 0.715 (95% CI: 0.708 to 0.732) based on bootstrapping validation. Conclusions: The ADC 3D texture feature can be used as a useful biomarker to predict the survival of ESCC patients undergoing CRT. Combining ADC 3D texture features with conventional prognostic factors can generate reliable survival prediction models.
基金:
This work was supported, in part, by the National Natural
Science Foundation of China under Grants 81530060,
81874224, and 81272501, the National Key Research and
Develop Program of China (Grant No. 2016YFC0105106),
the Provincial Key Research and Development Program
of Shandong (Grant No. 2017XZC1206), Taishan Scholars
Program of Shandong Province, China (Grant No.
ts20120505), Natural Science Foundation of Shandong
Province (Grant No. ZR2018BH028), and Engineering
Research Center for Medical Imaging and Radiation Therapy of
Shandong Province.
第一作者机构:[1]Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital, Jinan, China,
共同第一作者:
通讯作者:
通讯机构:[1]Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital, Jinan, China,
推荐引用方式(GB/T 7714):
Li Zhenjiang,Han Chun,Wang Lan,et al.Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy[J].FRONTIERS IN ONCOLOGY.2019,9:doi:10.3389/fonc.2019.01057.
APA:
Li, Zhenjiang,Han, Chun,Wang, Lan,Zhu, Jian,Yin, Yong&Li, Baosheng.(2019).Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy.FRONTIERS IN ONCOLOGY,9,
MLA:
Li, Zhenjiang,et al."Prognostic Value of Texture Analysis Based on Pretreatment DWI-Weighted MRI for Esophageal Squamous Cell Carcinoma Patients Treated With Concurrent Chemo-Radiotherapy".FRONTIERS IN ONCOLOGY 9.(2019)